Figure 1:

Figure 2.

Figure 3.

Figure 4.

Sequences of primers and thermocycling conditions
| Gene name [primers/probes reference] | Primer/Probe sequence | PCR technique Thermocycling conditions |
|---|---|---|
| β-globin [18] |
|
|
| BZLF1 [19] |
|
|
| LMP1 [19] |
|
|
| GAPDH [20] |
|
|
| PDLIM4 [21] |
|
|
| WIF1 [21] |
| |
| DAPK1 [this study] |
| |
| DNMT1 [20] |
|
|
| DNMT3B [this study] |
|
The correlation between the percent of global (5mC%) and local (TSGs promoters) methylation
| Parameter | PDLIM4 | WIF1 | DAPK1 |
|---|---|---|---|
| Pearson r | −0.4203 | −0.2904 | −0.3996 |
| 95% CI | −0.6743 to −0.07755 | −0.5763 to 0.05871 | −0.6604 to −0.05269 |
| P value (two-tailed) | 0.0186 | ns | 0.0259 |
Clinical characteristics of patients based on EBV infection status
| Clinical characteristics | EBV positive (n=11) | EBV negative (n=13) | |
|---|---|---|---|
| Age (years) | 57–77 (median: 66) | 44–71 (median: 59) | |
| Smoking | Yes | 5 (20.8%) | 13 (54.2%) |
| T stage | T1-T2 | 3 (12.5%) | 9 (37.5%) |
| T3-T4 | 8 (33.3%) | 4 (16.6%) | |
| N stage | N0-N1 | 8 (33.3%) | 3 (12.5%) |
| N2-N3 | 3 (12.5%) | 10 (41.7%) | |
| M stage | M0-M1 | 11 (45.8%) | 13 (54.2%) |
The characteristics of investigated group
| Clinical characteristics | Number of cases [n (%)] | |
|---|---|---|
| Age (years) | <65 / ≥65 | 11 (45.8%) / 13 (54.2%) |
| Smoking | Yes | 19 (79.2%) |
| Lymph node metastasis | Yes / No | 11 (45.8%) / 13 (54.2) |
| T stage | T1/T2 | 2/10 (8.3% / 41.7%) |
| T3/T4 | 9/3 (37.5% / 12.5%) | |
| N stage | N0/N1 | 5/6 (20.8% / 25%) |
| N2/N3 | 12/1 (50% / 4.2%) | |
| M stage | M0/M1 | 20/4 (83.3% / 16.7%) |